(Q48705293)

14 February 2018

title

beta-Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. (English)

1 reference

14 February 2018

1 reference

3

Lantos PL

1 reference

14 February 2018

author name string

Armstrong RA

series ordinal

1

1 reference

14 February 2018

Cairns NJ

series ordinal

2

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

14 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

14 February 2018

volume

227

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

193-196

1 reference

14 February 2018

Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

beta-Amyloid (A beta) deposition in elderly non-demented patients and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

A comparison of β-amyloid (Aβ) deposition in the medial temporal lobe in late-onset sporadic Alzheimer's disease, and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Subtypes and differential laminar distributions of ?A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Cortical Lewy body dementia: clinical features and classification

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Detection of Lewy bodies in Trisomy 21 (Down's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Neuritic plaques in the Lewy body variant of Alzheimer disease lack paired helical filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

Amyloid angiopathy in diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900343-1

7 January 2021

10.1016/S0304-3940(97)00343-1

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9185683

1 reference

14 February 2018